About

Zelicapavir Reduces Symptom Duration and Hospitalization in a Randomized, Double-Blind, Placebo-Controlled, International, Phase 2 Trial

Print PagePrint Page
Email AlertsEmail Alerts
RSS FeedsRSS Feeds
Contact IRContact IR